ConductScience.org, home

Gene · 10890

RAB10: RAB10, member RAS oncogene family

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. RAB10: RAB10, member RAS oncogene family. Genes, record 10890. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10890

On this page

Gene

Symbol
RAB10
HGNC
Name
RAB10, member RAS oncogene family
HGNC
NCBI Gene ID
10890
NCBI Gene
HGNC ID
HGNC:9759
HGNC
Ensembl
ENSG00000084733
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P61026Ras-related protein Rab-102004Ensembl, GeneID, HGNC

Source UniProt

Patents32

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1460629P61026Espacenet
EP 4650780 A22025-11-192389P61026Espacenet
JP 2025517970 A2025-06-122389P61026Espacenet
KR 1020250033494 A2025-03-1017P61026Espacenet
US 11834717 B22023-12-0518P61026Espacenet
US 11661461 B22023-05-30122P61026Espacenet
US 11446398 B22022-09-2070566P61026Espacenet
JP 2022524081 A2022-04-27173537P61026Espacenet
JP 2019054813 A2019-04-11241064P61026Espacenet
WO 2019034549 A12019-02-2118P61026Espacenet

1 to 10 of 32

See all 32 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,175

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleRAB10 papersNewest fiscal year
R01NS064934Mechanisms of LRRK2 Mediated Neurotoxicity172025
R01DK048370Small GTP Binding Proteins in Gastrointestinal Mucosa102025
ZIAAG000948Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease102025
P40OD010440Caenorhabditis Genetics Center92025
P30CA068485Cancer Center Support Grant72025
P30DK058404Molecular and Cellular Basis for Digestive Diseases72025
P30CA008748Cancer Center Support Grant62025
P30DK020593Vanderbilt Diabetes Research Center62025
P30EY008126Core Grant in Vision Research52025
P30CA016672Cancer Center Support Grant42025

1 to 10 of 1,175Source NIH's project files

See all 1,175 nih grants

Papers1,621

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Chemical Genetic Targeting of the LRRK2 GTPase Domain.bioRxiv202642818643PubTator, text miningPubMed
LRRK2: Molecular Mechanisms in Parkinson's Disease.Int J Mol Sci202642737506PubTator, text miningPubMed
Protocol to quantify LRRK2-mediated Rab10 phosphorylation using high-content imaging.STAR Protoc202642696457PubTator, text miningPubMed
DHA Targets RAB1B to Mediate the Driving Force Transmission of Copper Ion Vesicular Endocytosis Under Copper Overload for Promoting Cuproptosis and Ferroptosis in Hepatic Stellate Cells.Int J Biol Sci202642694667PubTator, text miningPubMed
Rab10 coordinates SADS-CoV non-lytic egress through the ERGIC-TGN-lysosome trafficking pathway.PLoS Pathog202642678995PubTator, text miningPubMed
Subtype-specific secretion of extracellular vesicles by LRRK2 and Rab GTPases under lysosomal stress.iScience202642630748PubTator, text miningPubMed
Glial control of extracellular α-synuclein propagation in LRRK2 Parkinson's disease.Adv Immunol202642629126PubTator, text miningPubMed
Rab10 Promotes Atlastin-Mediated Endoplasmic Reticulum Membrane Fusion.FASEB J202642561046PubTator, text miningPubMed
Large-scale functional annotation establishes a reference framework for human LRRK2 variants.medRxiv202642396337PubTator, text miningPubMed
Protective Effects of Taurine Against Zearalenone-Induced Quality Impairment During Porcine Oocyte Maturation.FASEB J202642333697PubTator, text miningPubMed

1 to 10 of 1,621

See all 1,621 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/10890

GET https://conductscience.org/api/genes/v1/10890/patents?page=2